Novela Neurotech showcases smart neural interface at Creative Destruction Lab
Novela Neurotech, a MedTech company developing AI-powered wireless, “smart” neural interface systems, joins Canada’s Creative Destruction Lab to further fine-tune its health technologies to the needs of patients with difficult neurological disorders. Read full article
Novela Neurotech begins testing wireless, read-write capable brain prosthesis
To further develop its wireless electrode for reading from and writing into the brain, Novela Neurotech is pleased to announce a new partnership with the Division of Comparative Medicine at the University of Toronto in Ontario, Canada. Read full article
A New Theory of Brain Organization takes aim at the Mystery of Consciousness
Consciousness is one of the brain’s most enigmatic mysteries. A new theory, inspired by thermodynamics, takes a high-level perspective of how neural networks in the brain transiently organize to give rise to memories, thought and consciousness. Read full article
Novela Neurotechnologies: Ushering in the Next-Generation of Personalized Neurological Care
The company develops biocompatible neural implants that monitor, recognize, and intervene in neurological disorders through personalized treatment protocols. Read full article
Novela Inaugurates R&D Center
Based in Ontario, Canada.
R&D Hub will facilitate collaboration with CRANIA and access to tier-1 talent in the Waterloo and Toronto areas.
January, we opened our research and development (R&D) center in Waterloo, Canada. Working in concert with the California headquarters, the center will focus on the advancement of the fabrication process of Novela’s neural implant devices.
Headed by Salam Gabran, Director of Engineering, the office is staffed by a team with impressive prior experience in medical devices microfabrication
“Toronto continues to draw upon world-class talent and cultivate a relentless entrepreneurial spirit. Incubators like MaRS and Innovation Guelph, as well as leading medical R&D centers like the University Health Network (UHN), and Ontario Brain Institute (OBI). Novela plans to establish a strong foothold in Ontario, and plans to collaborate with the Center for Advancing Neurotechnological Innovation to Application, CRANIA™,” says Ray Iskander, Novela’s CEO.
Novela’s Neureka™ and the Future of Neurostimulation
“Neurostimulation is emerging as a novel non-pharmacological way of treating brain disorders and is showing far greater efficacy with fewer side effects.” Read full article
In The Press
Novela’s hometown newspaper the Alameda Sun featured us in their Thursday 1/24/19 issue “Novela’s long-term vision is to extend memory and brain processing speed, and even to add built-in cloud connectivity as well as expand human senses.” Read full article
In The Spotlight
Mark Valentine, Senior VP, Business Development & IP Portfolio
“I’ve witnessed firsthand the need for medical devices and treatments in those regions less fortunate than the western world. I think that’s why I’m so attracted to medical devices and technology companies.” Read full article